tirzepatide우선순위 낮음근거 검토기타
LITERATURE DETAIL · PMID 42618422
Clinical efficacy of switching to tirzepatide in patients with type 2 diabetes and a high risk of metabolic dysfunction-associated steatotic liver disease undergoing GLP-1 receptor agonist therapy: Insights from the Hokkaido-TZP study.
Clinical efficacy of switching to tirzepatide in patients with type 2 diabetes and a high risk of metabolic dysfunction-associated steatotic liver disease undergoing GLP-1 receptor agonist therapy: Insights from the Hokkaido-TZP study.
- 저자
- Takao Takiyama, Hiroya Kitsunai, Fumika Maruyama, Naoyuki Kitao, Yoshinori Wakabayashi, Miki Ito
- 저널
- Journal of diabetes and its complications
- 공개일
- 2026 Aug 14
- 연구 유형
- 기타
- DOI
- 10.1016/j.jdiacomp.2026.109391
문헌 요약
To evaluate the clinical efficacy of switching from glucagon-like peptide-1 receptor agonists (GLP-1RAs) to tirzepatide in terms of metabolic and hepatic indices in patients with T2D at high risk of metabolic dysfunction-associated steatotic liver disease (MASLD). This multicenter, retrospective study comprised secondary analysis of the Hokkaido-TZP study…
PV 검토 포인트
누적 안전성 근거로 분류하고 기존 시그널과의 일관성을 확인합니다.